The ASAM Review Course in Addiction Medicine 2017 (20.5 CME)

5 (6 votes)

Overview

The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the exam and features an outstanding faculty. Over 800 professionals attend this popular course each time it is offered. ASAM’s Review Course has had a major impact on advancing a common base of scientific knowledge among physicians and other healthcare professionals.

Learning Objectives:

Upon completion, participants should be able to:

  • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse


  • Evaluation and Certificate - 2017 Review Course

    Contains 2 Component(s), Includes Credits

    This is the CME Evaluation for attendees of the 2017 Review Course.

    This is the CME Evaluation for attendees of the 2017 Review Course.

  • Session 5: Cannabis (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of Cannabis likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Cannabinoids
    • Management of Other Drug Intoxication and Withdrawal (Cannabinoids)

    Carla Marienfeld

    MD

    Carla Marienfeld, MD, is an addiction psychiatrist and an Associate Clinical Professor of Psychiatry at University of California San Diego. Clinically, she focuses on the treatment of patients with substance use disorders and co-morbid psychiatric conditions. She previously worked at a large outpatient addiction treatment program serving over 5000 patients. Her academic interests focus on implementation research and large-data health outcomes for patients with substance use disorders. She attended Baylor College of Medicine in Houston, TX, where she completed the International Health Track, served nationally on the Board of Trustees of the American Medical Student Association (AMSA), and earned Alpha Omega Alpha (AOA) Medical Honors Society and Honors distinction. During psychiatry residency at Yale, she served as chief resident, a National Institute of Drug Abuse R25 Research Fellow, and as the resident representative to the Accreditation Council for Graduate Medical Education (ACGME), while also earning several awards and fellowships. She completed a fellowship in Addiction Psychiatry at Yale. During residency and her early faculty years, she founded and led the Yale Global Mental Health Program. She served as the site training director for the Yale New Haven Hospital Addiction Psychiatry Fellowship and supervised and taught medical students for psychiatry, residents for global mental health, and fellows for addiction psychiatry. She has come to UCSD to help in the development and implementation of a new Addiction Recovery and Treatment Program and a new Addiction Psychiatry Fellowship.

  • Session 6: Stimulants (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of Stimulants likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Cocaine, Amphetamine and Other Stimulants
    • MDMA
    • Management of Other Drug Intoxication and Withdrawal (Cocaine, Stimulants)

    Petros Levounis

    MD, MA, DFASAM

    Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he received an MA degree in sociology from Stanford before moving to New York City where he trained in psychiatry at Columbia University. He graduated from Columbia receiving the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University. From 2002 to 2013, he served as director of the Addiction Institute of New York.
    Dr. Levounis has written numerous articles and monographs; has lectured extensively on addiction topics throughout the United States and abroad; and has been interviewed by all major television networks. Dr. Levounis serves on the Board of Directors of the American Society of Addiction Medicine (ASAM) and from 2005 to 2009 chaired the national Committee on Addiction Treatment of the American Psychiatric Association. Dr. Levounis is a Betty Ford Scholar, a recipient of a U.S. State Department Speaker and Specialist Award, a distinguished fellow of the APA and ASAM, and an honorary member of the World Psychiatric Association. 

    Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself,” the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders,” “The Behavioral Addictions,” “Motivational Interviewing for Clinical Practice,” “Becoming Mindful,” and the “Office-Based Buprenorphine Treatment of Opioid Use Disorder,” now in its second edition. His books have been translated into German, Hungarian, Japanese, Portuguese, and Spanish. 

    Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

  • Session 7: Other Classes of Drugs (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of Other Classes of Drugs likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Hallucinogens (LSD, Mescaline, Psilocybin, and Other Hallucinogens)
    • Dissociatives (Phencyclidine, Ketamine, Dextromethorphan and Other Dissociatives)
    • Inhalants (Nitrous Oxide, Hydrocarbons and Other Inhalants)
    • Anabolic Steroids
    • Management of Other Drug Intoxication and Withdrawal (Phencyclidine, Hallucinogens, Dissociatives, Inhalants, Steroids
    • Pharmacologic Interventions for Other Drug Dependence
    • Pharmacological Interventions for Non-Substance Related Addictions

    Erin A. Zerbo

    MD, FASAM

    Erin Zerbo, MD, FASAM is an Assistant Professor in the Department of Psychiatry at Rutgers New Jersey Medical School, and the Associate Director of Medical Student Education. She will serve as Director of the Wellness Center at University Hospital when it opens in Fall 2015.

    She received her B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology in 2003, and her M.D. from New York University School of Medicine in 2007. She continued in a psychiatry residency at New York University, where she served as chief resident during her PGY-IV year and received the Harold I. Kaplan Memorial Award for excellence in teaching and the Wendy Rives Memorial Award for compassion in working with the severely mentally ill. Following residency, she remained at NYU for a one-year fellowship in Addiction Psychiatry.

    Prior to her faculty position at Rutgers, Dr. Zerbo served as the Associate Director of the Consultation-Liaison Psychiatry Service at Bellevue Hospital and the Associate Director of the NYU Addiction Psychiatry fellowship.

    Dr. Zerbo's primary interest has always been the treatment of addiction in the context of public psychiatry. She is especially interested in the pharmacotherapy of substance use disorders among underserved populations, and in addressing systemic barriers to integrated and continuous care. Recent publications include a chapter entitled “Co-occurring Personality Disorders and Addiction" in The ASAM Principles of Addiction Medicine textbook, and an article accepted for publication in the Harvard Review of Psychiatry which explores how to improve attitudes of psychiatry residents toward patients with substance use disorders.

  • Session 8: Behavioral Addictions (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of Behavioral Addictions likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Non-substance Addictions: Gambling, Sex, Food
    • Pharmacological Interventions for Non-Substance Related Addictions

    Erin A. Zerbo

    MD, FASAM

    Erin Zerbo, MD, FASAM is an Assistant Professor in the Department of Psychiatry at Rutgers New Jersey Medical School, and the Associate Director of Medical Student Education. She will serve as Director of the Wellness Center at University Hospital when it opens in Fall 2015.

    She received her B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology in 2003, and her M.D. from New York University School of Medicine in 2007. She continued in a psychiatry residency at New York University, where she served as chief resident during her PGY-IV year and received the Harold I. Kaplan Memorial Award for excellence in teaching and the Wendy Rives Memorial Award for compassion in working with the severely mentally ill. Following residency, she remained at NYU for a one-year fellowship in Addiction Psychiatry.

    Prior to her faculty position at Rutgers, Dr. Zerbo served as the Associate Director of the Consultation-Liaison Psychiatry Service at Bellevue Hospital and the Associate Director of the NYU Addiction Psychiatry fellowship.

    Dr. Zerbo's primary interest has always been the treatment of addiction in the context of public psychiatry. She is especially interested in the pharmacotherapy of substance use disorders among underserved populations, and in addressing systemic barriers to integrated and continuous care. Recent publications include a chapter entitled “Co-occurring Personality Disorders and Addiction" in The ASAM Principles of Addiction Medicine textbook, and an article accepted for publication in the Harvard Review of Psychiatry which explores how to improve attitudes of psychiatry residents toward patients with substance use disorders.

  • Session 9: History of Addiction Treatment (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of The History of Addiction Treatment likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • History of Addiction Medicine
    • Treatment of Alcohol Use Disorders
    • Treatment of Drug Use Disorders
    • Linking Addiction Treatment With Other Medical and Psychiatric Treatment
    • Alternative Therapies for Alcohol and Drug Addiction
    • Non-Substance Addictions: Gambling, Sex, Food
    • Treatment Needs of Children and Adolescents
    • Treatment Needs of Seniors
    • Quality Management in Addiction Treatment

    Paul H. Earley

    MD, DFASAM

    Dr. Earley has worked in Addiction Medicine for over 30 years. He treats all types of addictive disorders and specializes in the assessment, treatment and management of health care professionals. As a therapist, he works with patients already in recovery, providing long term therapy for those who suffer from this disease. His professional expertise extends to advocacy for professionals before agencies and licensing boards. 

    Dr. Earley is a dynamic speaker and educator; he speaks and trains on topics of addiction, its treatment and addiction among health care professionals. In addition, he trains therapists about the neurobiological basis of psychotherapy. In his travels, he has provided training in the United States, Canada, the United Kingdom, Italy, Iceland and Switzerland.

    He is the author of two books and several research articles on addiction and its treatment. His most recent book, RecoveryMind Training is an innovative and comprehensive process designed to reengineer addiction treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) Textbook: Principles of Addiction Medicine, as author of the chapter: Physician Health Programs and Addiction among Physicians. He is a contributing author to the ASAM Criteria. His work was featured in the documentary series on addiction entitled Close to Home by Bill Moyers.

    Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia and the President-elect of the Federation of State Physician Health Programs (FSPHP). Dr. Earley is the current president-elect of the American Society of Addiction Medicine (ASAM). He is a Distinguished Fellow of ASAM and has served on the board of ASAM for over 14 years in several capacities.

  • Session 10: Neurobiology of Addiction (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of The Neurobiology of Addiction likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Animal Models of Addiction
      • Neuropharmacology
      • Acetylcholine
      • Norepinephrine
      • Dopamine
      • Serotonin
      • Gamma-Aminobutyric Acid (GABA)
      • Glutamate and NMDA Receptors
      • Other Amino Acids and Peptides
      • Endogenous Opioids
      • Endocannabinoids
    • Cellular and Molecular Mechanism in Addiction (Including Neuro-Adaptation, Epigenetic Phenomena, etc.)
    • Neuro-Imaging of Addiction and Related Phenomena (Craving, Relapse, Recovery, etc.)

    Petros Levounis

    MD, MA, DFASAM

    Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he received an MA degree in sociology from Stanford before moving to New York City where he trained in psychiatry at Columbia University. He graduated from Columbia receiving the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University. From 2002 to 2013, he served as director of the Addiction Institute of New York.
    Dr. Levounis has written numerous articles and monographs; has lectured extensively on addiction topics throughout the United States and abroad; and has been interviewed by all major television networks. Dr. Levounis serves on the Board of Directors of the American Society of Addiction Medicine (ASAM) and from 2005 to 2009 chaired the national Committee on Addiction Treatment of the American Psychiatric Association. Dr. Levounis is a Betty Ford Scholar, a recipient of a U.S. State Department Speaker and Specialist Award, a distinguished fellow of the APA and ASAM, and an honorary member of the World Psychiatric Association. 

    Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself,” the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders,” “The Behavioral Addictions,” “Motivational Interviewing for Clinical Practice,” “Becoming Mindful,” and the “Office-Based Buprenorphine Treatment of Opioid Use Disorder,” now in its second edition. His books have been translated into German, Hungarian, Japanese, Portuguese, and Spanish. 

    Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

  • Session 11: Epidemiology (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of Epidemiology likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Epidemiologic Associations and Interpretation
    • Biostatistics
      • Vital Statistics and Demography
      • Describing Data
      • Hypothesis Testing
      • Meta-Analysis
      • Measurements of Morbidity and Mortality
    • Incidence, Prevalence, and Initiation

    Jeffrey J. DeVido

    MD, MTS

    Dr. DeVido earned a Masters in Theological Studies from Harvard Divinity School, completed his medical schooling at Columbia University College of Physicians and Surgeons and adult psychiatry and addiction psychiatry training at Massachusetts General/McLean Hospitals.  In 2013, Dr. DeVido joined the faculty of UCSF as assistant professor working in consultation liaison psychiatry at the Parnassus Medical Center where he provided psychiatric evaluation and management of patients presenting to the emergency room and medical/surgical/intensive care units with co-occurring mental and medical illnesses.  He is a member of the board of directors of the American Academy of Addiction Psychiatry and sits on the American Psychiatric Association’s Council on Addictions, and he remains on faculty at UCSF.  He holds board certification in adult psychiatry, addiction psychiatry, and addiction medicine and he has published on a wide range of topics including issues related to medication assisted treatment and management of substance use disorders in pregnancy.  He recently joined the Department of Health and Human Services, Behavioral Health and Recovery Services in Marin County, CA, as the Chief of Addiction Services. 

  • Session 12: Definitions, The ASAM Criteria, and the DSM-5 (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of the Criteria, Definitions, and the DSM-5 likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Definitions
      • Addiction
      • Addiction Medicine
      • Unhealthy Use
      • Dependence
      • Withdrawal
      • Detoxification
      • Substance-Related Disorders
      • ICD-10 Diagnostic Categories
    • ASAM Patient Placement Criteria and Appropriate Use of Levels of Care

    Paul H. Earley

    MD, DFASAM

    Dr. Earley has worked in Addiction Medicine for over 30 years. He treats all types of addictive disorders and specializes in the assessment, treatment and management of health care professionals. As a therapist, he works with patients already in recovery, providing long term therapy for those who suffer from this disease. His professional expertise extends to advocacy for professionals before agencies and licensing boards. 

    Dr. Earley is a dynamic speaker and educator; he speaks and trains on topics of addiction, its treatment and addiction among health care professionals. In addition, he trains therapists about the neurobiological basis of psychotherapy. In his travels, he has provided training in the United States, Canada, the United Kingdom, Italy, Iceland and Switzerland.

    He is the author of two books and several research articles on addiction and its treatment. His most recent book, RecoveryMind Training is an innovative and comprehensive process designed to reengineer addiction treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) Textbook: Principles of Addiction Medicine, as author of the chapter: Physician Health Programs and Addiction among Physicians. He is a contributing author to the ASAM Criteria. His work was featured in the documentary series on addiction entitled Close to Home by Bill Moyers.

    Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia and the President-elect of the Federation of State Physician Health Programs (FSPHP). Dr. Earley is the current president-elect of the American Society of Addiction Medicine (ASAM). He is a Distinguished Fellow of ASAM and has served on the board of ASAM for over 14 years in several capacities.

  • Session 13: Cognitive Behavioral Therapy & Motivational Interviewing (.75 CME)

    Contains 3 Component(s), Includes Credits

    Experts in the field discuss aspects of Cognitive Behavior Therapy & Motivational Interviewing likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Psychological Aspects of Alcohol and Drug Use, Intoxication and Addiction (Including “Set and Setting," Placebo and Expectation)
    • Patient Engagement and Securing Treatment Entry
    • Motivating Patients to Change
    • Individual Psychotherapy
    • Cognitive Behavioral Therapy
      • Relapse Prevention
      • Community Reinforcement and Vouchers
      • Contingency Management
      • Matrix Model

    James W. Finch

    MD, DFASAM

    Dr. James Finch obtained his medical training at the University of South Florida College of Medicine and his residency training in Family Medicine at Lancaster General Hospital in Pennsylvania. Following a Faculty Development Fellowship at Duke University, he stayed on with the Duke Family Medicine Residency Program and with joint appointments in Family Medicine and Psychiatry, helped found and was Assistant Director of the Duke Addictions Program. After leaving Duke, Dr. Finch worked for many years in public sector mental health and substance abuse treatment and currently directs a private Addiction Medicine practice in Durham, NC called “Changes By Choice." He has continued to be active in local, national and international training initiatives, including the PCSS mentoring systems for buprenorphine and other opoiods, the SAMHSA sponsored Safe Opioid Prescribing workshops, and ongoing NC SBIRT initiatives in primary care and emergency room settings. He is the Clinical Training Director for Project Lazarus Community Care NC, a statewide initiative for safer use of opioid and other controlled medications. He is a Fellow of the American Society of Addiction Medicine, the Immediate Past President of the NC Society of Addiction Medicine and the Director of Physician Education for the NC Governor's Institute on Substance Abuse. His other life interests include being with his wife, Jane Blansfield Finch, an LCSW psychotherapist who is also an active Red Cross volunteer, three adult daughters and a grandson. He collects vintage and contemporary photography and attends modern dance and opera performances whenever possible.

    Petros Levounis

    MD, MA, DFASAM

    Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he received an MA degree in sociology from Stanford before moving to New York City where he trained in psychiatry at Columbia University. He graduated from Columbia receiving the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University. From 2002 to 2013, he served as director of the Addiction Institute of New York.
    Dr. Levounis has written numerous articles and monographs; has lectured extensively on addiction topics throughout the United States and abroad; and has been interviewed by all major television networks. Dr. Levounis serves on the Board of Directors of the American Society of Addiction Medicine (ASAM) and from 2005 to 2009 chaired the national Committee on Addiction Treatment of the American Psychiatric Association. Dr. Levounis is a Betty Ford Scholar, a recipient of a U.S. State Department Speaker and Specialist Award, a distinguished fellow of the APA and ASAM, and an honorary member of the World Psychiatric Association. 

    Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself,” the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders,” “The Behavioral Addictions,” “Motivational Interviewing for Clinical Practice,” “Becoming Mindful,” and the “Office-Based Buprenorphine Treatment of Opioid Use Disorder,” now in its second edition. His books have been translated into German, Hungarian, Japanese, Portuguese, and Spanish. 

    Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

The ASAM CME Committee and Reviewers Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

None

 

 

Catherine Friedman, MD

Vice Chair

None

 

  

Noel Ilogu, MD, MRCP, DFASAM

None

 

 

Hebert L. Malinoff, MD, FACP, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO

Indivior

BDSI

Honorarium

Honorarium

Speaker

Consultant/Speaker

 

The ASAM Review Course Program Planning Committee Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

 

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, INC

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

 

Stock Owned through IRA Rollover Account

Stock Owned through IRA Rollover Account

Stock Options

(Spouse)

 

Bonds in IRA

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Erin Zerbo, MD

None

 

 

 

The ASAM Review Course Faculty Member Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

Jeffrey DeVido, MD, MTS

Philip Morris

 

 

Altria

Ownership Interest

 

Ownership Interest

Equity Shareholder

 

Equity Shareholder

Paul H. Earley, MD, DFASAM

Alkermes

 

Georgia PHP, INC

 

Earley Counsultancy, LLC

 

DynamiCare Health, INC

Honoraria

 

Salary

 

 

Salary

 

 

 

Salary

Speaker

 

Medical Director

 

 

Principal

 

 

 

Speaker

James W. Finch, MD, DFASAM

Orexo Pharmaceuticals

 

Indivior Pharmaceuticals

Honoraria

 

 

Honoraria

Speaker

 

 

Speaker

Marc Fishman, MD, DFASAM

Alkermes

 

 

US WorldMeds

 

 

 

 

MediaRez

Salary

 

 

Salary

 

 

 

 

Research Funding

Consultant; Advisory Board

 

Consultant; Advisory Board; Principal Research Investigator

 

Principal Research Investigator

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, Inc

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

Stock Owned through IRA Rollover Account

Stock Owned through IRA

 

Rollover Account

Stock Options

(Spouse)

Bonds in IRA

Leslie Hayes, MD

None

 

 

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Richard Ries, MD, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Sharon Stancliff, MD

None

 

 

Timothy J. Wiegand, MD, FACMT, FAACT, FASAM

None

 

 

Erin Zerbo, MD

None

 

 

ACCME Accreditation Statement:

The American Society of Addiction Medicine is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians: 

This Live activity, The 2017 ASAM Review Course in Addiction Medicine & Pre-Courses, with a beginning date of 07/26/2017, has been reviewed and is acceptable for up to 27.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAM Transitional Maintenance of Certification Program (Tmoc)

This course has been approved by The American Board of Addiction Medicine (ABAM).  Physicians enrolled in the Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 20.5 AMA PRA Category 1 Credits

Upon completion, participants should be able to:

  • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

The ASAM Review Course in Addiction Medicine provides an up-to-date review of the core content of addiction medicine for:

  • Physicians preparing for the ABPM Board Certification/Recertification Examination in addiction medicine
  • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
  • Non-specialist physicians and other healthcare professionals needing the knowledge to identify and manage problems related to substance use disorders for their patients